D.
Nastić There was a significant difference in serum OC levels in all groups (p < 0.01); it was three times higher in group A than in group C. A similar increase was noticed for plasma iPTH, assuming that 'normal' uremic iPTH was elevated up to threefold above normal range (between 10 and 60 pg/ml) [4] . The total serum ALP activity was not as sensitive as OC and iPTH, since the increases were more prominent in OC and iPTH than in ALP. OC was age related only in group A (p < 0.01). Positive correlations were observed between OC and the duration of hemodialysis (p < 0.05), and between OC and serum phosphate (p < 0.05), but there was no correlation between OC and growth retardation, bone age and current therapy for renal osteo-dystrophy. A direct correlation between OC and ALP was found only in healthy children (p < O.Ol); in group A and B it was not statistically significant (p = 0.08). In group A, ALP and iPTH were directly correlated (p < 0.001), but the correlation between OC and iPTH was less significant (p = 0.06). In patients with CRF no correlation was found between glomerular filtration rate and OC. In summary, serum OC concentrations were significantly higher in children with terminal renal failure and CRF compared to healthy children of the same age. A positive correlation between OC and age and duration of chronic hemodialysis suggests that OC may be a useful noninvasive marker for the progredient course of hyperparathyroid bone disease in terminal renal failure. This could make it a suitable tool to target therapy with active vitamin D metabolites.
